SIX-MONTH ANTIBODY PERSISTENCE AFTER BNT162B2 MRNA COVID-19 VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Yair Herishanu; Irit Avivi; Shai Levi; Gabi Shefer; Yotam Bronstein; Miguel Morales Moshiashvili; Tomer Ziv; Lydia Scarfò; Chava Perry; Paolo Ghia